News
Net loss per basic and diluted share was $6.63 for the ... of the SCD therapy in 200 adults with AKI in the ICU receiving CRRT. The trial’s primary endpoint is a composite of 90-day mortality ...
9dOpinion
RealClearPolicy on MSNThe Washington Post Engages in Negligent Fear-Mongering About NIHIs the WaPo journalistically challenged when it comes to science? You decide. An April 6 article in the Washington Post, one ...
SeaStar Medical Fourth Quarter and Year-End 2024 Financial Results Conference Call Thursday, March 27, at 4:30 p.m. ET / 1:30 p.m. PT A replay of the call will be available after 7:30 pm ET and can be ...
An April 6 article in the WaPo, one of the most recent as the NIH undergoes administrative changes, claims, “A big step forward in cancer therapy has been slowed by layoffs and ...
CEO Vincent Angotti highlighted significant progress in the NEPHRO CRRT study, emphasizing the FDA-approved reduction in study size from 166 to 70 patients while maintaining 90% statistical power ...
We made strong progress in 2024 and anticipate furthering that progress in 2025 with the expectation that our NEPHRO CRRT study should be completed by the end of the year. We have a number of ...
NEPHRO CRRT Study Size Reduction: FDA approved reduction from 166 patients to 70, maintaining 90% power for the primary endpoint. Enrollment Ready Sites: Increased to eight, with plans to add five ...
Or perhaps you’ve tried before, only to get lost in a sea of tutorials that seemed to assume you already knew the basics. If that sounds familiar, you’re not alone—and the good news is ...
"Looking ahead to the KOURAGE readout, we are further encouraged by the promising readthrough from the data recently presented at the 30 th International AKI & CRRT Conference, which show a 62.7% ...
The best women's basics clothing brands are — or, should be — the foundation of your wardrobe. When you have a few simple pieces you love, getting dressed in the morning is much easier.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results